The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: A phase-III intergroup studyK B Miller, M J O'Connell, K. Kyungmann et al.|Annals of Hematology|1992Cited by 116
The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup studyK B Miller, M J O'Connell, Jane N. Winter et al.|Annals of Hematology|1993Cited by 115
Leukemic blasts fail to differentiate into mature antigen presenting cells, and may hinder dendritic cell maturation in vitro and in vivoJacalyn Rosenblatt, David Avigan, Richard M. Stone et al.|Journal of Clinical Oncology|2007Cited by 1
Leukemia derived dendritic cells (LDCs) may be ineffective as a cancer vaccine for acute myeloid leukemia (AML)Jacalyn Rosenblatt, David Avigan, Richard M. Stone et al.|Journal of Clinical Oncology|2005Cited by 1
63: Vaccination with dendritic cell myeloma fusions alone or in conjunction with stem cell transplantation for patients with multiple myelomaDavid Avigan, Donald Küfe, Jacalyn Rosenblatt et al.|Transplantation and Cellular Therapy|2007Cited by 0